Nouvelles Eulerpool Shanghai Fosun Pharmaceutical Group Co

Eulerpool-AFX Shanghai Fosun Pharmaceutical Group Co

Shanghai Fosun Pharmaceutical Group Co Actualités des actions

Shanghai Fosun Pharmaceutical Group Co est surveillé par de nombreux journalistes et investisseurs du monde entier. Nous regroupons ici les dernières actualités Shanghai Fosun Pharmaceutical Group Co.

• 28 août ·

  Yahoo
  Fosun Pharma Announces 2024 Interim Results
• 26 avril ·

  Yahoo
  Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa
• 8 mars ·

  SeekingAlpha
  Fosun Tourism At Crossroads As Parent Shops Its Two Major Assets
• 17 décembre ·

  SeekingAlpha
  Week In Review: SystImmune Out-Licenses Global Rights For ADC To BMS In $8.4B Deal
• 15 décembre ·

  Yahoo
  Fosun’s Hospital Arm Weighs $141 Million Funding Round, Sources Say
• 14 décembre ·

  Yahoo
  Fosun Pharma's Global Multi-Center Phase III Clinical Trial Project for A New Antimalarial Drug Receives 500 Million Japanese Yen Investment from GHIT Fund to Jointly Improve the Global Accessibility of Antimalarial Drugs
• 12 novembre ·

  Yahoo
  Fosun Pharma prepares to deliver Da Vinci surgical robots to make advanced medical treatment affordable to Chinese patients
• 20 septembre ·

  Yahoo
  Cevira Phase III trial for non-surgical HSIL treatment meets primary endpoint
• 7 septembre ·

  SeekingAlpha
  Debt Pressures Cast Cloud Over Fosun Pharma Results
• 30 août ·

  Yahoo
  Fosun Pharma Announces 2023 Interim Results: Continues to Promote Innovation Transformation and Optimizes Product Structure